Neogen Corp (NEOG)
12.02
-0.43
(-3.45%)
USD |
NASDAQ |
May 03, 16:00
12.26
+0.24
(+2.00%)
After-Hours: 20:00
Neogen Cash from Financing (TTM): 2.251M for Feb. 29, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
February 29, 2024 | 2.251M |
November 30, 2023 | -38.97M |
August 31, 2023 | -117.92M |
May 31, 2023 | -118.08M |
February 28, 2023 | -119.36M |
November 30, 2022 | -78.16M |
August 31, 2022 | 6.67M |
May 31, 2022 | 6.813M |
February 28, 2022 | 18.58M |
November 30, 2021 | 27.50M |
August 31, 2021 | 29.50M |
May 31, 2021 | 33.54M |
February 28, 2021 | 24.29M |
November 30, 2020 | 22.85M |
August 31, 2020 | 25.79M |
May 31, 2020 | 29.40M |
February 29, 2020 | 31.20M |
November 30, 2019 | 22.84M |
August 31, 2019 | 13.62M |
May 31, 2019 | 13.90M |
February 28, 2019 | 14.54M |
November 30, 2018 | 16.71M |
August 31, 2018 | 29.87M |
May 31, 2018 | 22.84M |
February 28, 2018 | 24.47M |
Date | Value |
---|---|
November 30, 2017 | 28.64M |
August 31, 2017 | 22.24M |
May 31, 2017 | 25.07M |
February 28, 2017 | 23.79M |
November 30, 2016 | 19.08M |
August 31, 2016 | 13.92M |
May 31, 2016 | 15.31M |
February 29, 2016 | 15.59M |
November 30, 2015 | 15.71M |
August 31, 2015 | 13.41M |
May 31, 2015 | 11.03M |
February 28, 2015 | 13.86M |
November 30, 2014 | 14.90M |
August 31, 2014 | 17.96M |
May 31, 2014 | 19.61M |
February 28, 2014 | 18.33M |
November 30, 2013 | 17.58M |
August 31, 2013 | 14.70M |
May 31, 2013 | 12.49M |
February 28, 2013 | 9.563M |
November 30, 2012 | 7.851M |
August 31, 2012 | 8.544M |
May 31, 2012 | 6.876M |
February 29, 2012 | 9.527M |
November 30, 2011 | 9.605M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-119.36M
Minimum
Feb 2023
33.54M
Maximum
May 2021
-8.187M
Average
16.24M
Median
Cash from Financing (TTM) Benchmarks
Moderna Inc | -821.00M |
Regeneron Pharmaceuticals Inc | -1.420B |
Syros Pharmaceuticals Inc | 43.46M |
Disc Medicine Inc | 239.38M |
Amylyx Pharmaceuticals Inc | 3.543M |